Texas House Bill HB3431

Texas 2025 - 89th Regular

• Filed: 2/26/25

Caption

Relating to prohibitions on the provision to certain children of gender transitioning or reassignment procedures and treatments and gender-affirming therapy and counseling; creating criminal offenses.

Impact

If enacted, HB3431 would substantially alter existing healthcare practices regarding gender identity issues for minors in Texas. It aligns with similar legislation passed in other states that seek to limit medical interventions for youth asserting transgender identities. The implications for state laws would include an increased focus on biological determinism in healthcare decisions for children, potentially setting a precedent for how gender identity is treated under Texas law and curtailing the ability for parents and guardians to access gender-affirming care for their children.

Summary

House Bill 3431 is a legislative proposal aimed at prohibiting the provision of gender transitioning or reassignment procedures and treatments to certain children in Texas. It seeks to restrict surgeries and medical treatments aimed at altering a child’s biological sex. Specifically, the bill outlines that physicians and healthcare providers would be barred from performing surgeries that could result in sterilization, prescribing puberty blockers, or providing treatments related to gender affirmation that are inconsistent with a child’s biological sex. Additionally, it imposes significant penalties for violations, classifying them as state jail felonies.

Contention

The bill has generated considerable debate, with proponents arguing it protects children from irreversible medical procedures that they may later regret. They emphasize the potential psychological and physical ramifications of gender-affirming treatments. Conversely, opponents assert that such legislation undermines the rights of parents and guardians to make informed health decisions for their children and could adversely affect the mental health of transgender youth. Critics argue that denying gender-affirming care contradicts guidance from major medical organizations, suggesting that it violates best practices in treating gender dysphoria.